Rhoda Baer / National Cancer Institute
July 25, 2012
A woman gets a mammogram to screen for breast cancer. A court of appeals ruled Friday that patents on the genes BRCA1 and BRCA2 held by Myriad Genetics, a biotech firm, are legal.
Currently there are no comments. Be the first to comment!